Sun Pharma Advanced Research Company

Sun Pharma Advanced Research Company

World Rank (Jan-05-2024)
6,345
Market Cap (Jan-05-2024)
1.662 Billion USD
World Rank (Jul-30-2023)
9,049
Market Cap (Jul-30-2023)
0.943 Billion USD
World Rank (Jan-07-2022)
8,751
Market Cap (Jan-07-2022)
1.141 Billion USD
World Rank (Jan-01-2021)
9,509
Market Cap (Jan-01-2021)
0.704 Billion USD
Headquarters Country
India
Market Cap (Mar-08-2026)
0.44
World Region
Asia
World Subregion
Southern Asia
Annual Revenue in USD
17 Million USD
Annual Net Income in USD
-25 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
35 Million USD
Total Liabilities in USD
31 Million USD
Total Equity in USD
4 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Company Website
Sun Pharma Advanced Research Company (SPARC)
Yahoo
Yahoo @ BSE
Company Profile
Sun Pharma Advanced Research Company is a clinical stage bio pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery. The company annual revenue is 1,372 million INR for year ending March 2022. The headquarters is in India.
ISIN Code
INE232I01014
Stock Category
S&P BSE HEALTH CARE
Stock Exchange
BSE
NSE
Company SubCategory
Top Healthcare Companies in India

Share